Hemochromatosis: Common genes, uncommon illness?

Canadian Family Physician

Volumn 48, Issue AUG., 2002, Pages 1326-1333

  Harrison, Helen ^a   Adams, Paul C ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; FERRITIN; HFE PROTEIN; HISTIDINE; IRON; TRANSFERRIN;

ARTICLE; CARDIOMYOPATHY; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EPIDEMIOLOGY; EUROPE; FAMILY STUDY; FATALITY; GENERAL PRACTITIONER; GENETIC ANALYSIS; GENETICS; HEMOCHROMATOSIS; HIGH RISK POPULATION; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CANCER; LIVER CIRRHOSIS; MASS SCREENING; MEDICAL LITERATURE; MEDLINE; PHLEBOTOMY; PREVALENCE; SCREENING TEST;

FAMILY PRACTICE; FERRITINS; GENETIC SCREENING; HEMOCHROMATOSIS; HUMANS; INCIDENCE; MASS SCREENING; PHYSICIAN'S ROLE; RISK FACTORS; TRANSFERRIN;

EID: 0036672760     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Population screening for haemochromatosis
2. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
3. Hereditary hemochromatosis: Gene discovery and its implications for population-based screening
4. Molecular aspects of iron absorption and HFE expression
5. Long-term survival in patients with hereditary hemochromatosis
6. Diagnosis and management of hemochromatosis
7. EASL International Consensus Conference on Haemochromatosis
8. Hemochromatosis and Iron Overload Screening Study (HEIRS): An interim analysis of 20,130 primary care persons
9. Penetrance of the 845G to A (C282Y) HFE hereditary hemochromatosis mutation
10. Screening for hemochromatosis - High prevalence and low morbidity in an unselected population of 65,238 persons
11. Non-expressing C282Y homozygotes for hemochromatosis: Minority or majority of cases?
12. A population-based study of the clinical expression of the hemochromatosis gene
13. Screening for hemochromatosis
14. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous hemochromatosis
15. Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods
16. 24-hour variation of transferrin saturation in treated and untreated hemochromatosis homozygotes
17. The effect of HFE genotypes on measurement of iron overload in patients attending a health appraisal clinic
18. A primer for predicting risk of disease in HFE-linked hemochromatosis
19. Molecular medicine and hemochromatosis: At the crossroads
20. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
21. Hepatocellular carcinoma in hereditary hemochromatosis
22. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis
23. Factors affecting rate of iron mobilization during venesection therapy for hereditary hemochromatosis
24. A survey of phlebotomy among persons with hemochromatosis
25. Psychosocial impact of C282Y mutation testing for hemochromatosis
26. Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping